- 全部删除
- 您的购物车当前为空
GNE-0723是一种选择性的NMDAR的阳性变构调节剂,对GluN2A的EC50=21nM,而GluN2C和GluN2D的EC50=6.2~7.4μM,具有可透过血脑屏障(BBB)的优点,可用于改善Dravet综合征(DS)和阿尔茨海默病(AD)。
GNE-0723是一种选择性的NMDAR的阳性变构调节剂,对GluN2A的EC50=21nM,而GluN2C和GluN2D的EC50=6.2~7.4μM,具有可透过血脑屏障(BBB)的优点,可用于改善Dravet综合征(DS)和阿尔茨海默病(AD)。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 3,230 | In stock | |
5 mg | ¥ 7,490 | In stock | |
10 mg | ¥ 9,870 | In stock | |
25 mg | ¥ 15,000 | In stock | |
50 mg | ¥ 19,800 | In stock |
GNE-0723 相关产品
产品描述 | GNE-0723 is a selective positive allosteric modulator of the NMDA receptor, with an EC50 of 21 nM for GluN2A. It can cross the blood-brain barrier (BBB) and improve outcomes in Dravet syndrome (DS) and Alzheimer's disease (AD). |
靶点活性 | GluN2C:7.4 μM(EC50), GluN2D:6.2 μM(EC50), GluN2A:21 nM (EC50) |
体外活性 | GNE-0723 是一种脑渗透性 NMDAR 正变构调节剂,对 GluN2A/2C/2D 的 EC50 为 21 nM/7.4μM /6.2 μM。[1] |
别名 | GNE0723 |
分子量 | 467.78 |
分子式 | C16H8ClF6N5OS |
CAS No. | 1883518-31-7 |
Smiles | C(F)(F)(F)C1=C(N2C(S1)=NC(CN3N=C(C(F)(F)F)C=C3Cl)=CC2=O)[C@H]4[C@H](C#N)C4 |
密度 | 1.84 g/cm3 (Predicted) |
存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 160 mg/mL (342.04 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容